First Line: Metformin
Dapagliflozin
$30.00 ~
Oxramet S XR 500 is a combination therapy for Type 2 Diabetes, containing Dapagliflozin (SGLT-2 Inhi...
Oxramet S XR 500 is a combination therapy for Type 2 Diabetes, containing Dapagliflozin (SGLT-2 Inhibitor) 10mg, Sitagliptin (DPP-4 Inhibitor) 100mg, and Metformin (First-Line Therapy) 500mg. This triple-action formula effectively lowers blood sugar levels by enhancing insulin sensitivity, reducing hepatic glucose production, and increasing glucose excretion through urine. As part of a comprehensive diabetes management strategy, Oxramet S XR 500 improves Glycemic Control, helps prevent Cardiovascular Diseases, and supports Liver Health by regulating hepatic glucose metabolism. This extended-release (XR) formulation ensures gradual absorption, reducing gastrointestinal side effects commonly associated with Metformin.